KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 77 filers reported holding KALA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,000 | -9.8% | 5,500 | 0.0% | 0.01% | -30.8% |
| Q3 2020 | $41,000 | -29.3% | 5,500 | 0.0% | 0.01% | -40.9% |
| Q2 2020 | $58,000 | +20.8% | 5,500 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $48,000 | +140.0% | 5,500 | 0.0% | 0.02% | +175.0% |
| Q4 2019 | $20,000 | -4.8% | 5,500 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $21,000 | -41.7% | 5,500 | 0.0% | 0.01% | -43.8% |
| Q2 2019 | $36,000 | -21.7% | 5,500 | 0.0% | 0.02% | -33.3% |
| Q1 2019 | $46,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 1,046,484 | $1,266,000 | 1.02% |
| RA Capital Management | 10,874,613 | $13,158,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $727,000 | 0.14% |
| Matisse Capital | 41,400 | $50,000 | 0.04% |
| Manteio Capital LLC | 19,546 | $24,000 | 0.03% |
| Covestor Ltd | 17,766 | $21,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 241,857 | $293,000 | 0.02% |
| Virtu Financial LLC | 126,231 | $153,000 | 0.02% |
| Aquatic Capital Management LLC | 6,200 | $8,000 | 0.02% |
| CAXTON CORP | 13,155 | $16,000 | 0.01% |